Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS??? EQUITY - Common Stock (Details)

v3.25.0.1
STOCKHOLDERS’ EQUITY - Common Stock (Details) - USD ($)
12 Months Ended
May 02, 2023
Apr. 20, 2023
Mar. 09, 2023
Feb. 22, 2023
Dec. 31, 2024
Dec. 31, 2023
May 02, 2024
Feb. 28, 2023
Feb. 02, 2023
Feb. 01, 2023
Subsidiary, Sale of Stock [Line Items]                    
Payments of stock issuance costs       $ 174,000            
Number of share based payment awards, exercised in period (in shares)         322,235 439,042        
Maverick Capital Partners, LLC | Convertible debt                    
Subsidiary, Sale of Stock [Line Items]                    
Face amount               $ 500,000    
Private Placement                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued in IPO (in shares) 1,000,000 16,666,666                
Shares issued in IPO, price per share (in dollars per share) $ 1.50 $ 1.50                
Aggregate offering price $ 1,100,000 $ 23,200,000                
Private Placement | Maverick Capital Partners, LLC                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued in IPO (in shares)     200,105              
Aggregate offering price     $ 500,000              
Sale of stock, maximum amount authorized                 $ 4,000,000  
Sale of stock, percentage of the average calculated volume weighted average price per share (as a percent)                 75.00%  
Private Placement | A.G.P./Alliance Global Partners                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued in IPO (in shares)       6,184            
Shares issued in IPO, price per share (in dollars per share)       $ 3.76            
Sale of stock, placement fee, percentage                   3.00%
Gross consideration received on transaction       $ 23,000            
Private Placement | Public Ventures, LLC                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued in IPO (in shares)         309,634          
Sale of stock, maximum amount authorized         $ 17,000,000   $ 17,000,000      
Sale of stock, amount remaining for future issuance, value         $ 16,200,000